These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35426769)

  • 1. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment.
    Doyle MA; Ling S; Lui LMW; Fragnelli P; Teopiz KM; Ho R; Di Vincenzo JD; Rosenblat JD; Gillissie ES; Nogo D; Ceban F; Jawad MY; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):733-743. PubMed ID: 35426769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.
    Halpern JH; Lerner AG; Passie T
    Curr Top Behav Neurosci; 2018; 36():333-360. PubMed ID: 27822679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation.
    Lev-Ran S; Feingold D; Rudinski D; Katz S; Arturo LG
    Am J Addict; 2015 Apr; 24(3):197-199. PubMed ID: 25808913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.
    Lev-Ran S; Feingold D; Frenkel A; Lerner AG
    J Dual Diagn; 2014; 10(2):79-83. PubMed ID: 25392249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinogen persisting perception disorder: what do we know after 50 years?
    Halpern JH; Pope HG
    Drug Alcohol Depend; 2003 Mar; 69(2):109-19. PubMed ID: 12609692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phenomena – Differential Diagnosis and Explanation Models].
    Hermle L; Ruchsow M; Täschner KL
    Fortschr Neurol Psychiatr; 2015 Sep; 83(9):506-15. PubMed ID: 26421858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.
    Martinotti G; Santacroce R; Pettorruso M; Montemitro C; Spano MC; Lorusso M; di Giannantonio M; Lerner AG
    Brain Sci; 2018 Mar; 8(3):. PubMed ID: 29547576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.
    G Lerner A; Goodman C; Bor O; Lev-Ran S
    Isr J Psychiatry Relat Sci; 2014; 51(4):277-80. PubMed ID: 25841224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The trip of a lifetime: hallucinogen persisting perceptual disorder.
    Anderson L; Lake H; Walterfang M
    Australas Psychiatry; 2018 Feb; 26(1):11-12. PubMed ID: 28836813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.
    Christensen JA; Fipps DC; Bostwick JM
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):300-304. PubMed ID: 36048112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature.
    Ford H; Fraser CL; Solly E; Clough M; Fielding J; White O; Van Der Walt A
    Front Neurol; 2022; 13():878609. PubMed ID: 35599738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.
    Lev-Ran S; Feingold D; Goodman C; Lerner AG
    Am J Addict; 2017 Sep; 26(6):568-571. PubMed ID: 28654720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallucinogen Persisting Perception Disorder and Risk of Suicide.
    Brodrick J; Mitchell BG
    J Pharm Pract; 2016 Aug; 29(4):431-4. PubMed ID: 25631475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flashbacks and HPPD: A Clinical-oriented Concise Review.
    G Lerner A; Rudinski D; Bor O; Goodman C
    Isr J Psychiatry Relat Sci; 2014; 51(4):296-301. PubMed ID: 25841228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.
    van Dongen RM; Alderliefste GJ; Onderwater GLJ; Ferrari MD; Terwindt GM
    Eur J Neurol; 2021 Aug; 28(8):2631-2638. PubMed ID: 33979006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hallucinogen persisting perception disorder after ecstasy use].
    Hanck L; Schellekens AF
    Ned Tijdschr Geneeskd; 2013; 157(24):A5649. PubMed ID: 23759176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
    Espiard ML; Lecardeur L; Abadie P; Halbecq I; Dollfus S
    Eur Psychiatry; 2005 Aug; 20(5-6):458-60. PubMed ID: 15963699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].
    Neven A; Blom JD
    Tijdschr Psychiatr; 2014; 56(11):748-52. PubMed ID: 25401683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.
    Schetz D; Schetz A; Kocić I
    Biomed Pharmacother; 2022 Feb; 146():112295. PubMed ID: 34980551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features.
    Lerner AG; Gelkopf M; Skladman I; Rudinski D; Nachshon H; Bleich A
    Int Clin Psychopharmacol; 2003 Mar; 18(2):101-5. PubMed ID: 12598822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.